The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-Positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy.
 
Neil M. Iyengar
No Relationships to Disclose
 
Lillian Mary Smyth
Consulting or Advisory Role - AstraZeneca; Roche/Genentech
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
 
Diana Lake
Consulting or Advisory Role - Genentech
 
Ayca Gucalp
Research Funding - Innocrin Pharma; Pfizer
 
Jasmeet Chadha Singh
No Relationships to Disclose
 
Tiffany A. Traina
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Genentech/Roche; Immunomedics; Medivation; Merck; Mundipharma; Pfizer
Research Funding - AstraZeneca; Eisai; Innocrin Pharma; Medivation; Myriad Genetics; Novartis; Pfizer
 
Patricia Anne DeFusco
No Relationships to Disclose
 
Maura N. Dickler
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; Merrimack; Novartis; Pfizer; Puma Biotechnology; Syndax; TapImmune Inc.
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst)
 
Monica N. Fornier
No Relationships to Disclose
 
Shari Beth Goldfarb
Consulting or Advisory Role - Sermonix Pharmaceuticals
Research Funding - Paxman
 
Komal L. Jhaveri
Consulting or Advisory Role - Dara Biosciences; Genentech; Samus Therapeutics
 
Shanu Modi
No Relationships to Disclose
 
Tiffany A. Troso-Sandoval
No Relationships to Disclose
 
Kellie Jack
No Relationships to Disclose
 
Gary Ulaner
No Relationships to Disclose
 
Maxine S. Jochelson
No Relationships to Disclose
 
Jose Baselga
Leadership - Infinity Pharmaceuticals; Varian Medical Systems
Stock and Other Ownership Interests - GRAIL; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma; Varian Medical Systems
Consulting or Advisory Role - Eli Lilly, Novartis; GRAIL
 
Larry Norton
No Relationships to Disclose
 
Clifford A. Hudis
Consulting or Advisory Role - Lilly; Merck; Novartis; Pfizer; Roche/Genentech
Other Relationship - Breast Cancer Research Foundation
 
Chau T. Dang
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Genentech